final results of core-001: cretostimogene plus pembrolizumab for bcg-unresponsive nmibc with cis
Published 3 months ago • 135 plays • Length 6:04Download video MP4
Download video MP3
Similar videos
-
0:27
cretostimogene plus pembrolizumab for bcg-unresponsive nmibc with cis #bladdercancer #cancer #news
-
2:02
dr li on cretostimogene grenadenorepvec plus pembrolizumab in bcg-unresponsive nmibc
-
2:08
core1 trial: cg0070 plus pembrolizumab for bcg-unresponsive carcinoma-in-situ bladder cancer
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
4:37
keynote-057: outcomes for patients with bcg-unresponsive nmibc who do not respond to pembrolizumab
-
3:17
n-803-bcg combination shows promising results in bcg-unresponsive nmibc
-
1:02
results of n-803, an il-15rαfc superagonist, with bcg in bcg-unresponsive cis and nmibc
-
1:37
dr. balar on next steps of the keynote-057 trial in nmibc
-
44:54
treatment and surveillance of non-muscle invasive bladder cancer - denver
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
2:11:15
aua2019 072ic: management of nmibc: practical solutions for common problems
-
6:08
immunotherapy approaches for nmibc
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
29:46
introduction to adstiladrin | gene therapy for bcg unresponsive nmibc
-
3:20
case 1: treatments for nmibc refractory to bcg
-
2:30
final os results of imvigor130: atezolizumab plus platinum/gemcitabine for muc
-
0:49
current standards in bcg-unresponsive carcinoma in-situ and papillary nmibc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer